At the news
? NEUTRALIMPACT 2/10 6-K filed Aug 12, 2026 at 09:49 ET
Genmab A/S filed its updated Articles of Association on August 11, 2026, via a Form 6-K on August 12, 2026. The filing is a routine corporate governance update, renewing existing authorizations for the Board of Directors to issue shares and warrants for employee incentive programs through March 2029/2030. The document details the terms of employee warrant schemes, including vesting schedules and exercise prices. No material financial data, changes in business operations, or new strategic initiatives were disclosed. The filing is administrative in nature and does not contain information that would materially impact the company's stock price.
- Genmab filed an updated set of Articles of Association on August 11, 2026.
- The Board of Directors' authorization to increase share capital without pre-emption rights (up to DKK 6.6M) is renewed through March 12, 2029.
- The Board of Directors' authorization to issue convertible debt instruments (up to DKK 3M nominal) is renewed through March 12, 2029.
- Multiple employee warrant schemes are detailed, with grants issued from 2017 through June 2026, all with exercise prices at or above market price at time of grant.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access